Haleon (HLN) Change in Account Payables (2022 - 2023)
Haleon (HLN) posted Change in Account Payables of $127.8 million for Q4 2023, down 24.31% on a QoQ basis from $168.9 million in Q4 2022, and down 24.31% year-over-year from $168.9 million in Q4 2022.
Haleon (HLN) Change in Account Payables (2022 - 2023) Analysis & Trends
Haleon's Change in Account Payables history runs 2 years deep, the most recent figure standing at $127.8 million for Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.46 Bn | 87.60 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.21 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.69 Bn | 30.75 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 27.61 Bn | 23.55 Bn | 4.39 Bn | 30.60 Mn |
| 5 | United Therapeutics | 23.21 Bn | 21.06 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.32 Bn | 18.51 Bn | 1.16 Bn | 32.70 Mn |
| 8 | Neurocrine Biosciences | 17.84 Bn | 16.53 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.52 Bn | 10.37 Bn | 59.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 127.84 Mn |
| Dec 31, 2023 | 127.84 Mn |
| Dec 31, 2022 | 168.90 Mn |
| Dec 31, 2022 | 168.90 Mn |